Cargando…
The antagonism of 6-shogaol in high-glucose-activated NLRP3 inflammasome and consequent calcification of human artery smooth muscle cells
BACKGROUND: Vascular calcification is the major reason for high mortality of cardiovascular complications for diabetes. Interleukin (IL)-1β has been implicated in this pathogenesis, but its precise role and clinical evidence have not been clearly identified. Hence, this study was aimed to investigat...
Autores principales: | Chen, Te-Chuan, Yen, Chia-Kung, Lu, Ying-Chen, Shi, Chung-Sheng, Hsieh, Rong-Ze, Chang, Shun-Fu, Chen, Cheng-Nan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953308/ https://www.ncbi.nlm.nih.gov/pubmed/31938471 http://dx.doi.org/10.1186/s13578-019-0372-1 |
Ejemplares similares
-
6-Shogaol Antagonizes the Adipocyte-Conditioned Medium-Initiated 5-Fluorouracil Resistance in Human Colorectal Cancer Cells through Controlling the SREBP-1 Level
por: Lee, Ko-Chao, et al.
Publicado: (2021) -
Comparison of Inhibitory Capacities of 6-, 8- and 10-Gingerols/Shogaols on the Canonical NLRP3 Inflammasome-Mediated IL-1β Secretion
por: Ho, Su-Chen, et al.
Publicado: (2018) -
6-Shogaol Exhibits Anti-viral and Anti-inflammatory
Activity in COVID-19-Associated Inflammation by Regulating NLRP3 Inflammasomes
por: Kode, Jyoti, et al.
Publicado: (2023) -
The Role of NLRP3 Inflammasome Activities in Bone Diseases and Vascular Calcification
por: Yu, Chenyang, et al.
Publicado: (2020) -
6-shogaol is a potential treatment for Head and Neck Squamous Cell Carcinoma
por: Hsu, Cheng-Ming, et al.
Publicado: (2023)